Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4823 | BGMS Bio Green Med Solution, Inc. - Common Stock | 0.82 USD | -3.53% | -6.82% | -5.75% | -84.62% | 5.43 M USD | ||
| 4833 | CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 USD | +14.74% | +9.67% | +17.11% | +68.94% | 5.08 M USD | ||
| 4837 | XBIO Xenetic Biosciences, Inc. - Common Stock | 2.12 USD | -4.07% | -7.83% | -48.92% | -75.60% | 4.97 M USD | ||
| 4838 | LIMN Liminatus Pharma, Inc. - Class A Common Stock | 3.69 USD | -4.65% | -1.60% | +4.24% | +138.06% | 4.96 M USD | ||
| 4845 | NCNA NuCana plc - American Depositary Shares | 1.13 USD | -0.88% | -5.83% | -16.91% | -47.44% | 4.70 M USD | ||
| 4848 | XTLB XTL Biopharmaceuticals Ltd - American Depositary Shares | 1.98 USD | 0.00% | -8.76% | -20.16% | +120.00% | 4.68 M USD | ||
| 4857 | ENLV Enlivex Ltd. - Ordinary Shares | 0.28 USD | -9.68% | -33.33% | -73.08% | -76.07% | 4.43 M USD | ||
| 4863 | DRMA Dermata Therapeutics, Inc. - Common Stock | 1.07 USD | -4.46% | -7.76% | -11.57% | -25.17% | 4.30 M USD | ||
| 4864 | PMCB PharmaCyte Biotech, Inc. - Common Stock | 0.40 USD | -2.44% | -2.44% | -16.67% | -60.00% | 4.29 M USD | ||
| 4873 | ERNA Ernexa Therapeutics Inc. - Common Stock | 2.49 USD | +4.18% | -17.00% | -36.64% | +611.43% | 4.06 M USD | ||
| 4878 | ADXN Addex Therapeutics Ltd - American Depositary Shares | 3.18 USD | +6.71% | +4.26% | -13.35% | -63.78% | 3.92 M USD | ||
| 4886 | PCSA Processa Pharmaceuticals, Inc. - Common Stock | 1.35 USD | -4.93% | -21.97% | -32.16% | -39.19% | 3.77 M USD | ||
| 4891 | GRI GRI Bio, Inc. - Common Stock | 1.68 USD | -9.19% | -16.00% | -6.15% | -36.60% | 3.67 M USD | ||
| 4897 | EVGN Evogene Ltd. - Ordinary Shares | 0.40 USD | -2.44% | -2.44% | -20.00% | -69.92% | 3.49 M USD | ||
| 4899 | SXTP 60 Degrees Pharmaceuticals, Inc. - Common Stock | 0.97 USD | -11.82% | -24.22% | +3.19% | -40.85% | 3.41 M USD | ||
| 4901 | CVKD Cadrenal Therapeutics, Inc. - Common Stock | 0.93 USD | -4.12% | -5.10% | -20.51% | -83.15% | 3.32 M USD | ||
| 4905 | APVO Aptevo Therapeutics Inc. - Common Stock | 1.80 USD | -2.17% | 0.00% | -2.70% | -73.33% | 3.24 M USD | ||
| 4909 | REVB Revelation Biosciences, Inc. - Common Stock | 0.78 USD | -6.02% | -3.70% | -22.00% | -43.48% | 3.11 M USD | ||
| 4912 | MLEC Moolec Science SA - Ordinary Shares | 4.19 USD | -12.89% | -13.61% | -38.38% | +398.81% | 3.04 M USD | ||
| 4918 | MBIO Mustang Bio, Inc. - Common Stock | 0.41 USD | -8.89% | -12.77% | -24.07% | -52.87% | 2.97 M USD |
Noticias Biotechnology Stocks
El fármaco de Pharvaris para el angioedema hereditario muestra alivio más rápido
Raymond James inicia cobertura de Kymera Therapeutics con Mejor Rendimiento
Raymond James inicia cobertura de Nektar con calificación de rendimiento de mercado
Palisade Bio inicia cobertura con Mejor Rendimiento según Raymond James
Raymond James reitera su calificación de Liquidia en medio de presentaciones legales
Tenax Therapeutics pausa temporalmente la inscripción en el ensayo LEVEL-2 de TNX-103 para modificar los criterios; solicita reunión con la FDA
Ginkgo Bioworks apoyará a los X-Labs de la NSF con acceso a su laboratorio
Gainers Biotechnology Stocks
GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |